Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

874 ARTÍCULOS , VIENDO DEL 496 AL 510

Low/High Multi-Frequency Stimulation of the Subthalamic Nucleus Improves Verbal Fluency Maintaining Motor Control in Parkinson's Disease

Ricciardi L, Cucinotta F, Pegolo E, Abundes-Corona A, Ishihara B, Hossain I, Sawacha Z, Hart M, Pereira E, Morgante F, Fasano A.

Mov Disord. 2025 Sep;40(9):1892-1900. doi: 10.1002/mds.30254. Epub 2025 Jun 11.

Clinical Diagnosis of Progressive Supranuclear Palsy (PSP): A Clinicopathological Comparison of Patients with Confirmed PSP and Clinical Mimics

Wrigley S, Cullinane PW, Parmera JB, Arca VM, Sifontes Valladares W, Rivera-Sánchez M, Curless T, Chajed LP, Burrows M, Revesz T, Morris HR, Jaunmuktane Z, Warner TT, de Pablo-Fernández E.

Mov Disord. 2025 Oct;40(10):2116-2128. doi: 10.1002/mds.30261. Epub 2025 Jun 12.

[Drug-induced Parkinsonism as Viewed from Neurologist]

Tomiyama M.

Brain Nerve. 2025 Jun;77(6):715-719. doi: 10.11477/mf.188160960770060715.

Magnetic Resonance Image-Guided Focused Ultrasound Ventral Intermediate Nucleus Thalamotomy with Indwelling Globus Pallidus Internus Deep Brain Stimulation Electrodes: A Case Report

Glaser AC, Liu DD, White PJ, Ferenczi EA, Hung AY, McDannold NJ, Cosgrove GR.

Stereotact Funct Neurosurg. 2025;103(4):263-268. doi: 10.1159/000546737. Epub 2025 Jun 16.

Novel Kinesin Family Member 1A Variants Linked to Atypical Parkinsonism Elicit Altered Neuronal Transactive Response DNA Binding Protein 43 kDa Interactions and Dendritic Atrophy

Homayoun H, DeChellis-Marks MR, Kofler J, Fricklas G, Gleixner AM, Yeh FC, Lacomis D, Chu CT, Donnelly CJ.

Am J Pathol. 2025 Nov;195(11):2161-2175. doi: 10.1016/j.ajpath.2025.05.018. Epub 2025 Jun 19.

Inspiratory muscle training for people with Parkinson's disease: a protocol for a mixed methods randomised controlled trial

Fernandes Barreto de Mendonca J, Preston E, Flynn A, Bissett B.

BMJ Open Respir Res. 2025 Jun 22;12(1):e003120. doi: 10.1136/bmjresp-2024-003120.

Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented population

Yadav R, Dey S, Kumar R, Mohanan AP, Vasudevan GT, Harish M, Kamble N, Holla VV, Mahale RR, Mailankody P, Debnath M, Saini J, Kumar K, Mahadevan A, Subramanian S, Alladi P, Datta I, Sreekumarannair BV, Thomas P, Mehta A, Stezin A, Ingalhalikar M, Ramdas S, Bathula DR, Pal PK.

PLoS One. 2025 Jun 26;20(6):e0325624. doi: 10.1371/journal.pone.0325624. eCollection 2025.

GAN-based Denoising for Scan Time Reduction and Motion Correction of 18 F FP-CIT PET/CT: A Multicenter External Validation Study

Han H, Choo K, Jeon TJ, Lee S, Seo S, Kim D, Kim SJ, Lee SH, Yun M.

Clin Nucl Med. 2025 Oct 1;50(10):e580-e588. doi: 10.1097/RLU.0000000000006040. Epub 2025 Jul 1.

Biallelic ELOVL1 Variants Are Linked to Hypomyelinating Leukodystrophy, Movement Disorder, and Ichthyosis

Wong KM, Maroofian R, Meier K, Diegmann S, Tkemaladze T, Alvi JR, Tasharrofi B, Efthymiou S, Munchau A, Korenke GC, Almontashiri N, Eyaid W, Kashgari A, Alotaibi M, Gärtner J, Huppke B, Asadollahi M, Chikvinidze G, Keramatipour M, Sultan T, Thiele H, Nürnberg P, Gräler MH, Houlden H, Huppke P.

Mov Disord. 2025 Sep;40(9):1836-1850. doi: 10.1002/mds.30258. Epub 2025 Jul 1.

Comparison of Two MPTP Doses on Mouse Behaviors and Pathologies

Qi Y, Zhang Z, Xue J, Yao S, Lu X, Tang X.

FASEB J. 2025 Jul 15;39(13):e70822. doi: 10.1096/fj.202500467RR.

Disease-Modifying Trials in Treated Parkinson's Disease: "Stable Treated" Does Not Equate with Biological Stability

Mouradian MM, Stoessl AJ, Lang AE.

Mov Disord. 2025 Sep;40(9):1778-1790. doi: 10.1002/mds.30259. Epub 2025 Jul 10.

Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder

Yska HAF, Golse M, Beerepoot S, Hayer S, Bergner C, de Paiva ARB, Marelli C, Palacios NJ, Osorio YL, Huiban C, Franke G, Wortmann F, Holtick U, Ayrignac X, van der Knaap MS, Schöls L, Perlbarg V, Galanaud D, de Witte MA, Wolf NI, Nguyen S, Mochel F; and the International CSF1R‐RD Working Group.

Mov Disord. 2025 Sep;40(9):1826-1835. doi: 10.1002/mds.30282. Epub 2025 Jul 11.

Deciphering the Janus-Faced Nature of the Apolipoprotein Superfamily in Parkinsonian Neurodegeneration: Molecular Crosstalk Between the Astroglial Secretome and Neuronal Homeostasis

Dai Y, Bi M, Jiao Q, Du X, Chen X, Yan C, Jiang H.

Mov Disord. 2025 Nov;40(11):2299-2313. doi: 10.1002/mds.30294. Epub 2025 Jul 14.

Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease: A Randomized Noninferiority Trial

Vaughan CP, Morley JF, Lehosit J, McGwin G, Muirhead L, Khakharia A, Johnson TM 2nd, Evatt ML, Sergent T, Burgio KL, Markland AD.

JAMA Neurol. 2025 Sep 1;82(9):925-931. doi: 10.1001/jamaneurol.2025.1904.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias